Revumenib sesquifumarateProduct ingredient for Revumenib

Name
Revumenib sesquifumarate
Drug Entry
Revumenib
Accession Number
DBSALT003460
Structure
Synonyms
BENZAMIDE, N-ETHYL-2-((4-(7-((TRANS-4-((ETHYLSULFONYL)AMINO)CYCLOHEXYL)METHYL)-2,7-DIAZASPIRO(3.5)NON-2-YL)-5-PYRIMIDINYL)OXY)-5-FLUORO-N-(1-METHYLETHYL)-, (2E)-2-BUTENEDIOATE (2:3) / trans N-ethyl-2-((4-(7-((4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide sesquifumarate salt
External IDs
SNDX 50613 / SNDX 5613 / SNDX-50613 / SNDX-5613 / SNDX50613 / SNDX5613
UNII
75HI05N8HS
CAS Number
2169919-22-4
Weight
Average: 1609.86
Monoisotopic: 1608.705582535
Chemical Formula
C76H106F2N12O20S2
InChI Key
AXNUWYROYVRYIM-OQIJCFCCSA-N
InChI
InChI=1S/2C32H47FN6O4S.3C4H4O4/c2*1-5-39(23(3)4)31(40)27-17-25(33)9-12-28(27)43-29-18-34-22-35-30(29)38-20-32(21-38)13-15-37(16-14-32)19-24-7-10-26(11-8-24)36-44(41,42)6-2;3*5-3(6)1-2-4(7)8/h2*9,12,17-18,22-24,26,36H,5-8,10-11,13-16,19-21H2,1-4H3;3*1-2H,(H,5,6)(H,7,8)/b;;3*2-1+/t2*24-,26-;;;
IUPAC Name
tris((2E)-but-2-enedioic acid); bis(N-ethyl-5-fluoro-N-(propan-2-yl)-2-{[4-(7-{[(1r,4r)-4-ethanesulfonamidocyclohexyl]methyl}-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl]oxy}benzamide)
SMILES
OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.CCN(C(C)C)C(=O)C1=CC(F)=CC=C1OC1=C(N=CN=C1)N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(=O)(=O)CC)CC2.CCN(C(C)C)C(=O)C1=CC(F)=CC=C1OC1=C(N=CN=C1)N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(=O)(=O)CC)CC2
ChEMBL
CHEMBL4650278
Predicted Properties
PropertyValueSource
logP3.37Chemaxon
pKa (Strongest Acidic)11.81Chemaxon
pKa (Strongest Basic)9.35Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count7Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area107.97 Å2Chemaxon
Rotatable Bond Count26Chemaxon
Refractivity171.88 m3·mol-1Chemaxon
Polarizability69.55 Å3Chemaxon
Number of Rings10Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon